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Summary
Background: Cancers develop in a complex mutational land-
scape. Interaction of genetically abnormal cancer cells with
normal stromal cells can modify the local microenvironment
to promote disease progression for some tumor types. Ge-
netic models of tumorigenesis provide the opportunity to
explore how combinations of cancer driver mutations confer
distinct properties on tumors. Previous Drosophila models of
EGFR-driven cancer have focused on epithelial neoplasia.
Results: Here, we report aDrosophila genetic model of EGFR-
driven tumorigenesis in which the neoplastic transformation
depends on interaction between epithelial and mesenchymal
cells. We provide evidence that the secreted proteoglycan
Perlecan can act as a context-dependent oncogene cooperat-
ing with EGFR to promote tumorigenesis. Coexpression of
Perlecan in the EGFR-expressing epithelial cells potentiates
endogenousWg/Wnt and Dpp/BMP signals from the epithelial
cells to support expansion of a mesenchymal compartment.
Wg activity is required in the epithelial compartment, whereas
Dpp activity is required in the mesenchymal compartment.
This genetically normal mesenchymal compartment is
required to support growth and neoplastic transformation of
the genetically modified epithelial population.
Conclusions: We report a genetic model of tumor formation
that depends on crosstalk between a genetically modified
epithelial cell population and normal host mesenchymal cells.
Tumorigenesis in this model co-opts a regulatory mechanism
that is normally involved in controlling growth of the imaginal
disc during development.Introduction
During development, different cell types within an organ
communicate through interactions involving direct cell-cell
contact, secreted signaling molecules, and extracellular
matrix (ECM). The interchange of information guides the orga-
nization of the cells into tissues and organs and later contrib-
utes to tissue homeostasis. Solid tumors also contain different
cell types. However, during tumorigenesis, the communication
between these cell types may be disrupted so that tissue
homeostasis is destabilized. The tumor becomes a structurally
and functionally abnormal organ [1, 2]. ECM is a critical
element mediating crosstalk between cell types during
normal development, and expression of ECM components is
frequently deregulated in some cancers [3]. Understanding
how ECM modulates interactions between the tumor cells*Correspondence: hherranz@imcb.a-star.edu.sg (H.H.), scohen@imcb.
a-star.edu.sg (S.M.C.)and their stromal environment will be important for under-
standing disease progression.
Cancers display another level of complexity: tumors accu-
mulate mutations. Signaling via EGFR promotes tissue growth
duringnormal development, andactivatingmutations inEGFRs
have been recognized as driver mutations in human cancer [4].
Although expression of EGFRs is altered in many epithelial
tumors, cooperation with multiple oncogenic lesions is
required for disease progression [5]. Cancer genome sequence
data have identified multiple genetic abnormalities present in
cancer cells [6]. However, the relevance ofmost of thosemuta-
tions in cancer remains unclear. Function-based evidence for
the involvement of previously unrecognized genes in tumor for-
mation could offer new insights into disease mechanisms.
Carcinomas originating in epithelial tissues are among
the most-common human cancers. Drosophila imaginal disc
epithelia have been successfully used to study tumor progres-
sion and oncogenic cooperation [7–11](reviewed in [12]). The
study of cell interactions and cell-ECM interactions in tumori-
genesis likewise calls for simple genetic models that can reca-
pitulate these features of the disease in vivo.
Here, we report that misregulation of the ECM component
Perlecan cooperates with EGFR in tumor formation in a
Drosophila tumor model. Perlecan, the product of the
Drosophila gene trol, is a secreted heparan sulfate proteogly-
can (HSPG). Perlecans stabilize growth factor-receptor
signaling complexes and have roles in diverse developmental
processes and in disease [13–16]. Perlecan upregulation co-
operates with EGFR in formation of tumors that are composed
of a mix of mutant epithelial cells and wild-type mesenchymal
cells, resembling the organization observed in some human
tumors [2]. We show that the oncogene-expressing epithelial
cells promote cell proliferation and amplification of the endog-
enous mesenchymal cell population. Reciprocally, the mesen-
chymal cell population is required to support tumor growth,
indicating that bidirectional crosstalk between the genetically
modified epithelial cells and their otherwise normal mesen-
chymal neighbors is required for tumor formation.
Results
Synergistic Interaction between pipsqueak and EGFR
EGFR overexpression in imaginal disc epithelial cells leads to
benign tissue hyperplasia, accompanied by MAPK pathway
upregulation ([17]; Figures 1A and 1B). When combined with
other cooperating factors, such as bantammicroRNA (miRNA)
expression, EGFR overexpression can lead to neoplasia and
metastasis [11]. Several other miRNAs were found to coop-
erate with EGFR to produce tumors, including miR-10 and
miR-375. pipsqueak (psq) was predicted to be a target of these
two miRNAs. When depleted on its own, psq did not cause an
obvious overgrowth phenotype (Figure 1C), but depletion of
psq in cells overexpressing EGFR led to massive tissue over-
growth (Figure 1D; efficacy of psqRNAi is shown in Figure S1
available online). Three independent psqRNAi lines produced
comparable effects.
EGFR-expressing discs normally retain a pseudostratified
epithelial arrangement, and cells show normal apicobasal
Figure 1. psq Downregulation Cooperates with
EGFR in Tumor Formation
(A–D) Confocal micrographs of third instar wing
imaginal discs of the following genotypes:
apG4:UAS-GFP (A); apG4:UAS-EGFR, UAS-GFP
(B); apG4:UAS-psqRNAi, UAS-GFP (C); and
apG4:UAS-EGFR, UAS-psqRNAi, UAS-GFP (D).
Note that the optical section in (D) underesti-
mates the volume of the tissue, in comparison
to the flat imaginal discs in (A)–(C), which retained
normal epithelial organization. DNA was labeled
with DAPI (red). GFP is shown in green. Scale
bars of (A)–(D) represent 100 mm.
(E–G) Confocal micrographs of apG4:UAS-EGFR,
UAS-psqRNAi, UAS-GFP tumorous discs dis-
sected 4 days (E) and 7 days (F and G) after
Gal4 induction. (G) Optical cross-section of the
disc shown in (F). DE-Cadherin is shown in red,
and GFP is shown in green. DNA was labeled
with DAPI (blue).
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1477polarity [11]. Overproliferation is partially offset by elevated
levels of apoptosis. In contrast, discs expressing EGFR with
psqRNAi grew as large multilayered masses (for convenience,
these will be called EGFR-psqRNAi). Optical sections of the
EGFR-psqRNAi discs after 4 days of growth revealed a complex
morphology, with layers of GFP-expressing cells intermingled
with populations of cells that did not express GFP (Figure 1E).
The GFP-positive cells formed epithelial sheets, with normal
apicobasal polarity, revealed by apical accumulation of DE-
Cadherin (Figure 1E). By 7 days growth, DE-Cadherin uni-
formly outlined the cells but did not show a polarized apical
localization (Figures 1F and 1G), suggesting that the epithelial
organization of the GFP-positive cells had been lost. Islands of
GFP-positive cells were intermingled with groups of cells not
expressing GFP.
EGFR-psqRNAi Discs Undergo Neoplastic Transformation
and Metastasize
EGFR-psqRNAi larvae did not enter pupariation, and the discs
continued to grow, often filling the anterior half of the larva
(Figures 2A and 2B). GFP-positive masses were frequentlyseen growing at ectopic sites in these animals (Figure 2B,
arrows). We observed invasion of the GFP-positive imaginal
disc cells into internal organs, including the gut andmalphigian
tubules (Figures 2C and 2D). Matrix metalloprotease-1 (Mmp1)
expression was upregulated compared to control discs (Fig-
ures 2E and 2F). An mmp-1 lacZ reporter showed that mmp1
expression was broadly induced in the epithelial cells (Fig-
ure S2A). Consistent with elevated expression of the secreted
Mmp1, basement membranes were degraded in these discs
(Figures 2G and 2H; for further examples, see Figures S2B–
S2E). mmp1-lacZ induction reflects activation of the JNK
pathway [18]. These observations suggest that the EGFR-
psqRNAi tissue had undergone neoplastic transformation and
had become metastatic, displaying key characteristic fea-
tures: epithelial-mesenchymal transition (EMT), accompanied
by disruption of the basement membrane as a consequence
of upregulation of matrix metalloproteases [18, 19].
Multiple Tissue Types in EGFR-psqRNAi Tumors
We were intrigued by the observation that these tumorous
discs contained a mixture of GFP-positive epithelial cells andFigure 2. EGFR-psqRNAi Tumors Undergo EMT
(A and B) Low-magnification images showing
whole larvae of the following genotypes:
apG4:UAS-EGFR, UAS-GFP (A) and apG4:UAS-
EGFR, UAS-psqRNAi, UAS-GFP (B). Note the
massive expansion of the GFP-expressing tissue
and the many small GFP-expressing metastases
(some examples are highlighted by the arrows).
(C and D) Examples of GFP-positive metastases
invading the gut (C) and the malphigian tubule
(D). GFP labels the mutant cells (green, gray).
Actin is shown in red. DNA was labeled with
DAPI (blue).
(E and F) ap-Gal4:UAS-GFP control and ap-
Gal4:UAS-EGFR, UAS-psqRNAi, UAS-GFP wing
discs showing GFP (green), Mmp1 (red, gray),
and DNA (blue).
(G and H) Wild-type control and ap-Gal4:UAS-
EGFR, UAS-psqRNAi wing discs showing base-
ment membrane labeled with a Collagen IV-GFP
fusion protein (vkg-GFP; green). The basement
membrane was partially degraded in the EGFR-
psqRNAi discs. DNA was labeled with DAPI (red).
Figure 3. Complex Tissue Morphology in EGFR-
psqRNAi Tumorous Discs
(A) Third instar imaginal disc showing the adepi-
thelial myoblast cells with anti-Twist (Twi; red).
DNA was labeled with DAPI (blue). Inset at right
shows an optical cross-section of the thorax
showing myoblasts (red) below the epithelium.
(B) The main panel shows optical XY section
of apG4:UAS-EGFR, UAS-psqRNAi, UAS-GFP
tumorous disc. The bottom and right panels
show XZ and YZ sections of the same wing discs
at the level of the white lines. Twist protein (red,
gray) labels myoblasts. GFP (green, gray) labels
the epithelia. DNA was labeled with DAPI (blue).
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epithelial organization over time, they retained GFP expres-
sion. Labeling with antibodies to Twist and Cut proteins iden-
tified the GFP-negative population as mesenchymal cells,
which resemble adepithelial myoblast cells (Figures 3A and
3B; Figure S3A). Adepithelial cells are normally located below
the portion of the wing disc epithelium that makes the thoracic
body wall (notum). Proximity of the EGFR-psqRNAi-expressing
cells to the adepithelial population proved to be important for
tumor formation. Use of nubbin-Gal4, which is specific to the
wing pouch, produced epithelial hyperplasia but no tumors,
whereas two different Gal4 drivers whose expression domains
included the notum region produced tumors (Figure S3B). The
EGFR-psqRNAi tumors consisted of a mixture of genetically
modified GFP-positive epithelial cells and a population of un-
modified endogenous mesenchymal cells.
Signaling from the Epithelial Cells to the Mesenchymal
Cells
The presence of an extensive mesenchymal cell population in
the tumors suggested that their expansion might be driven by
signals from the EGFR-psqRNAi-expressing epithelial cells. A
brief 20 min 5-ethynyl-20-deoxyuridine (EdU) pulse labeledFigure 4. Interaction between Epithelial and Mesenchymal Cells Required for
(A and B) Optical sections of apG4:UAS-EGFR, UAS-psqRNAi, UAS-GFP tumoro
Individual channels are shown in gray. DNAwas labeled with DAPI (blue). The ep
channels.
(C) Portion of a tumorous disc showing the percentage of proliferating cells in
mesenchymal cells (GFP negative) close to epithelial cells, and PH3-positive me
Numbers represent counts from one optical section from each of ten different
(D) Optical section of apG4:UAS-EGFR, UAS-psqRNAi tumorous disc showing p
(E) Optical section of an apG4:UAS-EGFR, UAS-psqRNAi tumorous disc showin
(F) Third instar wing imaginal discs of the following genotypes: apG4:UAS-EGF
dppRNAi (right). Green shows GFP (left) and EGFR (right). DNA is shown in red.many epithelial and mesenchymal cells in the tumors, indi-
cating that proliferation of both populations was rapid (Fig-
ure 4A). To get a more-precise view of proliferation in these
discs, we made use of an antibody specific to the phosphory-
lated form of histone H3 (PH3), which selectively labels cells
undergoing mitosis [20]. Because M phase is relatively short,
fewer dividing cells were captured in each tumorous disc,
allowing a more-accurate definition of where division was
taking place (Figure 4B). Counting PH3-positive cells showed
that proliferation of the epithelial and mesenchymal cells was
comparable but that most of the dividing mesenchymal cells
were adjacent to the epithelial layer (Figure 4C). These obser-
vations suggest local expansion of the mesenchymal popula-
tion in the response to cues from the epithelial cells.
Dpp and Wg are important drivers of proliferation within the
imaginal disc epithelia [21, 22]. An antibody to the phosphory-
lated form of the Dpp signal transducer MAD showed elevated
pMAD label in the mesenchymal cells adjacent to the epithelial
layers, indicative of elevated Dpp signaling activity (Figure 4D).
Notably, the intensity of the pMAD signal decreased with dis-
tance from the epithelium, suggesting that the EGFR-psqRNAi
tissue served as the source of Dpp. Consistent with this, we
observed dpp expression in the epithelial population by usingTumorigenesis
us discs, showing EdU in red (A) and PH3 in red (B). GFP is shown in green.
ithelial cell population is shaded green in the EdU (A) and PH3 (B) separated
different regions: PH3-positive epithelial cells (GFP positive), PH3-positive
senchymal cells separated at least three cell diameters from epithelial cells.
tumorous discs.
MAD protein (red). GFP is shown in green. DNAwas labeled with DAPI (blue).
g dpp-lacZ expression (red). Gal4 is shown in green. DNA is shown in blue.
R, UAS-psqRNAi, UAS-GFP (left) and apG4:UAS-EGFR, UAS-psqRNAi, UAS-
Figure 5. Perlecan Cooperates with EGFR in Tumor Formation
(A) Perlecan mRNA measured by quantitative real-time PCR. RNA was prepared from discs of the indicated genotypes. Data were normalized to rp49. The
data show mean 6 SD from three technical replicates of a representative experiment. Comparable results were obtained in independent experiments.
(B) Optical section of the thoracic region (notum) of awild-type third instar wing imaginal disc showing Perlecan (green) andDNA (blue). The red line indicates
the border between the main epithelium (E) and the populations of adepithelial myoblast cells (M).
(C) Optical section of an apG4:UAS-EGFR, UAS-psqRNAi tumorous disc. Perlecan is shown in green. Cut (red) labels myoblasts.
(D) Confocal micrograph of an apG4:UAS-EGFR, UAS-psqRNAi, UAS-GFP third instar wing imaginal disc, labeled as indicated.
(E) Confocal micrograph of an apG4:UAS-EGFR, UAS-psqRNAi, UAS-PerlecanRNAi third instar wing imaginal disc, labeled as indicated. The UAS-Perle-
canRNAi transgene (VDRC110494) replaces the UAS-GFP transgene compared to the control in (D).
(F) Cross-section of an apG4:UAS-EGFR, UAS-psqRNAi, UAS-PerlecanRNAiwing disc. Perlecan is shown in green. Cut is shown in red. DAPI is shown in blue.
(G) Confocal micrograph of an apG4:UAS-EGFR, UAS-GFP third instar wing imaginal disc, labeled as indicated.
(H) Confocal micrograph of an apG4:UAS-EGFR, UAS-GFP, UAS-Perlecan third instar wing imaginal disc, labeled as indicated.
Scale bars of (D)–(H) represent 100 mm.
(I and J) Optical sections of apG4:UAS-EGFR, UAS-Perlecan, UAS-GFP tumorous discs. Twi protein (red in the merge), GFP (green), and DNA (blue) are
shown in (I). pMAD (red in the merge), GFP (green), and DNA (blue) are shown in (J).
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tion to visualize dpp mRNA (Figure S4A). To test whether this
Dpp activity was required for tumorous growth of the discs,
we coexpressed a UAS-RNAi transgene to deplete Dpp in
the EGFR-psqRNAi tissue. Preventing Dpp expression in the
epithelial cells led to a striking reduction of the growth of the
tumorous discs (Figure 4F). Similar results were obtained for
Wg, which was upregulated in the EGFR-psqRNAi tissue and
was required for tumorous overgrowth (Figure S4B).
Perlecan Cooperates with EGFR in Tumor Formation
HSPGs serve as cofactors for Wnt and Dpp signaling [16]. We
noted that the intensity of pMAD labeling in the epithelial cells
themselves was lower than it was in the nearby mesenchymalcells (Figure 4D). This suggested that HSPGs might be
involved in potentiating growth factor signaling in the mesen-
chymal cells. Because only the epithelial cells were genetically
modified, we focused on secreted HSPG, which might be able
to act on the mesenchymal cells. Perlecan is a secreted HSPG
that has been linked to FGF, Hedgehog, Wg, Unpaired, and
Dpp activity [23–27]. We observed that depletion of psq in
epithelial cells was sufficient to increase the level of perlecan
mRNA (Figure 5A). This did not require coexpression of
EGFR. In control discs, antibody labeling showed Perlecan
on the basement membrane toward the outer face of
the disc epithelial and adepithelial layers (Figure 5B). In the
EGFR-psqRNAi discs, Perlecan accumulated on the mesen-
chymal cells (Figures 5C and S5A).
Figure 6. Wing Mesenchymal Cells Are Required
for Tumor Formation
(A) Confocal micrograph of 15B03-Gal4:UAS-
RFP; UAS-FLP; Ubi>STOP>GFP. Permanent
labeling of 15B03-Gal4 cells results in labeling
of myoblasts, but not epithelia cells (RFP; red).
GFP is shown in green. DNA is shown in blue.
Right panels show an optical cross-section of
the thoracic region of the same disc in which
the red label can be seen to be adepithelial cells
beneath the disc epithelium.
(B) 15B03-lexA:lexAop-GFP third instar wing
disc. GFP is shown in blue. DNA is shown in red.
(C) 15B03-lexA:lexAop-rpr third instar wing disc.
Cut (green) labels myoblasts. DNA is shown in
red. Inset shows an optical cross-section of the
thoracic region of the same disc. Note the reduc-
tion in the number of myoblasts.
(D) apG4:UAS-EGFR; UAS-psqRNAi; UAS-GFP
tumorous disc. GFP is shown in green. Cut is
shown in red. DNA is shown in blue. Scale bar
of (D) represents 100 mm.
(E) apG4:UAS-EGFR, UAS-psqRNAi; 15B03-lexA:
lexAop-reaper third instar wing disc. EGFR is
shown in green. Cut is shown in red. DNA is
shown in blue. Scale bar of (E) represents 100 mm.
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we coexpressed a UAS-PerlecanRNAi transgene in EGFR-
psqRNAi epithelial cells. Perlecan depletion prevented the
tumorous growth caused by the EGFR-psqRNAi combination
(Figures 5D and 5E). Similar results were obtainedwith an inde-
pendentUAS-PerlecanRNAi line (Figure S5B). Remarkably, Per-
lecan depletion also restored normal apicobasal polarity and
tissue organization to the EGFR-psqRNAi epithelial cells (Fig-
ure 5F). This suggested that Perlecan overexpression is
required for the neoplastic transformation of the EGFR-
psqRNAi tissue.
Overexpression of Perlecan with EGFR proved to be
sufficient to drive massive overgrowth and neoplastic
transformation (Figures 5G and 5H). Expression of Perlecan
alone, without coexpression of EGFR, had little effect on
growth of the disc (Figure S5C). The discs coexpressing
EGFR and Perlecan resembled EGFR-psqRNAi discs in
certain ways: the intermingling of epithelial and mesen-
chymal populations and the elevated Dpp signaling in
the mesenchymal cells adjacent to the epithelia (Figures
5I and 5J). These findings suggest that when over-
expressed, Perlecan behaves as a context-dependent
oncogene capable of cooperating with EGFR to produce
tumors. Upregulation of Perlecan may be the key conse-
quence of the cooperation between psq depletion and
EGFR expression.The Mesenchymal Population Is
Required for Epithelial Tumor
Formation
The observation that depleting Perlecan
suppressed all features of the tumorous
growth of the EGFR-psqRNAi imaginal
discs prompted us to ask whether
the expansion of the mesenchymal
compartment was required for the
epithelial overgrowth and loss of epithe-
lial organization. To address this ques-
tion, we needed a method that wouldallow us to independently control gene expression in the
epithelial and mesenchymal cell populations. We made use
of the two-component lexA system [28] to manipulate expres-
sion in themesenchymal cells, while usingGal4 in the epithelial
cells. We prepared a lexA operator transgene that expressed
the proapoptotic gene reaper and crossed this to the 15B03-
lexA driver, which is expressed in the adepithelial cells. As a
control for specificity of the 15B03 driver line, we performed
lineage tracing, which showed that 15B03-Gal4 was never ex-
pressed in wing disc epithelial cells (Figure 6A). 15B03-lexA-
driven reaper expression reduced the size of the population
Cut expressing adepithelial cells (Figures 6B and 6C). Ablation
of the adepithelial cells in this way effectively suppressed the
neoplastic transformation phenotype in the EGFR-psqRNAi
imaginal discs (Figures 6D and 6E). Interestingly, in the wild-
type discs, ablation of the adepithelial cells led to reduction
in the size of the epithelium comprising the notum region
(Figure 6C).
Dpp Signaling in the Mesenchymal Population Is Required
for Epithelial Tumor Formation
Both Wg and Dpp were expressed in the epithelial cell
population in EGFR-psqRNAi imaginal discs and were required
for tumorigenesis (Figures4andS4). Interestingly,coexpression
ofWgandDpp, togetherwithEGFR in theepithelial cells,proved
to be sufficient for tumorigenesis (Figures 7A–7D): both were
Figure 7. Wg and Dpp Cooperate with EGFR in Tumor Formation
Confocal micrographs of third instar wing discs of the following genotypes:
(A) apG4:UAS-EGFR, UAS-GFP.
(B) apG4:UAS-EGFR, UAS-wg.
(C) apG4:UAS-EGFR, UAS-dpp.
(D and E) apG4:UAS-EGFR, UAS-wg, UAS-dpp.
(F) apG4:UAS-EGFR, UAS-psqRNAi, UAS-GFP.
(G) apG4:UAS-EGFR, UAS-psqRNAi, UAS-tcf DN.
(H) apG4:UAS-EGFR, UAS-psqRNAi, UAS-MadRNAi.
(I) apG4:UAS-EGFR, UAS-psqRNAi; 15B03-lexA:lexAop-MadRNAi.
GFP is shown in green in (A) and (C)–(F). EGFR is shown in green in (B) and (I). Cut is shown in red in (E). DNA is shown in blue in (A)–(D) and (F)–(I).
(J) Schematic representation of the crosstalk between the epithelial and mesenchymal cell populations in tumor formation. Wild-type: EGFR, Wg, and Dpp
signaling are required to support proliferation of the disc epithelial cells. Dpp produced by the epithelial cells is also required to support the mesenchymal
population. EGFR-psq tumor: increased EGFR activity leads to increased production ofWg andDpp.Wg signaling is required within the epithelial cells. Dpp
is no longer required in the epithelial cells, but elevated signaling enhances growth of the mesenchymal population. Under normal circumstances, this leads
to hyperplasia. Depletion of pipsqueak (psq) leads to increased expression of the secretedHSPG, Perlecan (Pcn). Pcn potentiates Dpp activity in themesen-
chymal population, presumably by increasing capture of Dpp by the mesenchymal cells. An as-yet-unidentified signal (growth factor), which feeds back to
promote proliferation of the epithelial cells, is produced by the mesenchymal cells. This combination of signaling activities leads to neoplasia.
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1482required. As in the case of EGFR coexpression with Perlecan,
increased expression of Wg and Dpp with EGFR produced tu-
mors consisting of epithelial andmesenchymal cell populations
and showing loss of epithelial integrity (Figure 7E). These find-
ings suggest that Perlecan acted as an oncogene by sensitizing
the tissue to the endogenous Wg and Dpp induced by EGFR
overexpression (Figure S5C).
Next, we asked whether Wg and Dpp activities were
required in the epithelial cells or in the mesenchymal popula-
tion to elicit tumorous growth. Expression of a TCF domi-
nant-negative transgene [29] was used to block Wg signaling
in the epithelial cells. This blocked EGFR-psqRNAi tumor
formation (Figures 7F and 7G). In contrast, expression of a
UAS-MadRNAi transgene to block Dpp signaling in the epithe-
lial cells did not reduce tumorous growth (Figure 7H). Given
that pMAD levels were elevated in mesenchymal cells close
to the epithelial cells of the EGFR-psqRNAi tumorous discs (Fig-
ure 4D), we sought to address the role of Dpp signaling in the
mesenchymal cells. We prepared a lexA operator transgene
that expressed theMadRNAi transgene and expressed this un-
der control of the 15B03-lexA driver. Reducing Dpp signaling
in the mesenchymal population proved to be sufficient to
reduce tumorous growth (Figure 7I). These experiments pro-
vide evidence that Wg is required in the epithelial cells,
whereas Dpp activity is required in the mesenchymal
population.
Discussion
Accumulating evidence indicates that tumor progression
results from the interaction between tumor cells and the sur-
rounding normal cells that make up the tumor microenviron-
ment [2, 30, 31]. Here, we have used theDrosophilawing imag-
inal disc to dissect the crosstalk between tumor cells and
surrounding normal cells, in tumors of epithelial origin. In this
model, interaction between the two cell populations is
required for tumor growth, neoplastic transformation of the
epithelium, andmetastasis, even though the genetic modifica-
tions were introduced into only one of the two cell populations.
The signaling relationships between the two cell populations
are depicted schematically in Figure 7J.
Carcinomas express growth factors involved in the commu-
nication between cancer cells and tumor-associated normal
cells [31–34]. The role of TGF-b and Wnt signaling pathways
in tumor initiation is well known [35–37], but their role as medi-
ators of the interaction between tumor cells and stromal cells
has been less well studied. We observed that EGFR overex-
pression induced expression of the endogenous Wg and
Dpp genes in the epithelial compartment of the tumors. Wg,
together with EGFR, is needed in the epithelial cells to drive
tumorous growth. The role of the Dpp pathway is different.
Our findings indicate that Dpp, produced by the epithelial
cells, acts on the mesenchymal stromal cells. Dpp signaling
activity was not required in the epithelial cells themselves
for tumorous growth. Instead, downregulation of the Dpp
pathway in mesenchymal cells blocked tumorous growth of
the epithelial population. This suggests that Dpp signaling
elicits a feedback response from the mesenchymal popula-
tion. As a consequence, the resulting tumors are composed
of a mix of mutant epithelial cells and genetically normal
mesenchymal cells, resembling organization observed in
human tumors.
EGFR is upregulated in many carcinomas. EGFR is able to
promote tissue overgrowth, but additional mutations arerequired for malignant transformation and invasion [7, 11,
38–40]. Our findings have shown that upregulation of Perlecan
is sufficient to cooperate with EGFR to produce neoplastic
transformation. Perlecan is a secreted HSPG of the ECM that
is overexpressed in many human tumor types (reviewed in
[14]). TGF-b ligands have been shown to promote changes in
the tumor microenvironment in mammals (reviewed in [34]).
Perlecan has also been reported to stabilize Wg and promote
Wg activity in Drosophila [27]. Thus, Perlecan production
could potentiate the effects of Dpp and Wg produced by the
epithelial cells. These findings raise the possibility that Perle-
cans might have a fundamental role in mediating interactions
between epithelial tumor cells andmesenchymal stromal cells,
in addition to their known roles in tumor angiogenesis [14].
The crosstalk between tumor and microenvironment deter-
mines the phenotype of the tumor. Signaling from the tumor
microenvironment can suppress the malignant tumor pheno-
type, yet the tumormicroenvironment can also promotemalig-
nant transformation [31]. Our finding that ablation of the
mesenchymal cell population reverted the tumor phenotype
in this model suggests that signals from the mesenchymal
cells are required for tumor progression. This same cell popu-
lation was required to support growth of the epithelial popula-
tion in a nontumorous normal tissue context.We postulate that
signals from the adepithelial mesenchymal cells sustain prolif-
eration of the epithelial cells and likewise that signals from the
epithelia drive proliferation of the mesenchymal cells. This
normal feedback mechanism can be coopted to drive growth
of the two tissues, as, for example, when EGFR and Perlecan
were overexpressed. A remarkable, unexpected aspect of
these findings is that this feedback loop appears to be suffi-
cient to drive the epithelial tissue beyond hyperplasia, through
neoplastic transformation, and into metastasis.
Experimental Procedures
Drosophila Strains
15B03-lexA and 94D09-Gal4 were provided by Gerry Rubin. mmp1-lacZ is
described in [18], and dpp-lacZ (BS3.0) reporter is described in [41]. UAS-
psqRNAi (Vienna Drosophila RNAi Center [VDRC] 106404), UAS-wgRNAi
(VDRC 13352), UAS-PerlecanRNAi (VDRC 110494), and UAS-MadRNAi
(VDRC 110517) were obtained from the VDRC. ap-Gal4, UAS-psqRNAi
(#35419), UAS-psqRNAi (#28693), 15B03-Gal4 (#49261), UAS-dppRNAi
(#25782), UAS-PerlecanRNAi (#42783), EP-trol (used to overexpress Perle-
can; #11007), UAS-tcf DN (described in [29]), and dpp-lacZ were obtained
from the Bloomington Stock Center. vkg-GFP, also known as vkgG454, is
described in [42]. Lineage tracing with the LexA15B03 driver was performed
as described in [43].
Regulated Overgrowth using Gal80ts
In experiments involving use of the Gal4/Gal80 system to direct tissue over-
growth, embryos were collected from crosses of the indicated genotypes
for 24 hr at 18C and allowed to develop at 18C for 5 days to maintain
the Gal80-dependent repression of Gal4 until the larvae reached early third
instar. Larvae were then transferred to 29C to induce Gal4 activity and
grown for 5 days at 29C before being processed for immunostaining.
Immunostaining
Primary antibodies used in these experiments were as follows: Rabbit anti-
Gal4 (Santa Cruz Biotechnology); rabbit anti-b-gal (Cappel); rat anti-DE-
Cadherin (DCAD2); mouse anti-Mmp1 (3A6B4/5H7B11/3B8D12 antibodies
were mixed in equal amounts); mouse anti-Cut (2B10); mouse anti-Wg
(4D4) (Developmental Studies Hybridoma Bank); rabbit anti-pH3 (Cell
Signaling Technology); anti-pMAD (provided by Ed Laufer); rat anti-EGFR
(provided by P. Rørth); rabbit anti-Perlecan (provided by Stefan Baumgart-
ner); rabbit anti-Twi (provided by Maria Leptin); and rabbit anti-Psq (pro-
vided by Celeste Berg). Alexa Fluor 635 phalloidin was used to label F-actin
(Life Technologies). The Click-iT EdU Alexa Fluor 594 (Molecular Probes,
A Genetic Model for Tumor-Stroma Interaction
1483Invitrogen) was used to detect cells in S phase following the manufacturer’s
protocol.
Quantitative Real-Time PCR
RNAwas extracted using Trizol (Invitrogen) and treated with DNase I (Prom-
ega), and oligo-dT-based reverse transcription was performed using the
superscript III system (Invitrogen). Real-time quantification was performed
using SYBR green reagents on an ABI 7500 Fast Real-Time PCR System
(Applied Biosystems).
Construction of pLexAop-reaper and pLexAop-MadRNAi
DNA encoding the reaper gene was PCR amplified from cDNA clone
IP02530 (Berkeley Drosophila Genome Project) as a 50-XhoI to 30-XbaI frag-
ment and cloned into pJFRC19 [28], replacing the myr-GFP reporter. DNA
encoding an inverted repeat targeting mad was PCR amplified from
genomic DNA, using primers 50-CGCGGATCCCGCCAAGCAGAAGGAG
GTGTG-30 and 50-CGCTCTAGACAGAAGGCGGGCTCCGAATAG-30 (adapt-
ed from [44]), and was subcloned into pJFRC19 at the XbaI site. Microinjec-
tion was performed to target the construct to the attP2 landing site.
Supplemental Information
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at http://dx.doi.org/
10.1016/j.cub.2014.05.043.
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